Exam (elaborations)
Systemic Therapies for Cancer (LM 12.1) exam questions and answers
- Course
- Institution
Erlotinib - An inhibitor that targets epidermal growth factor receptor (EGFR) Midostaurin - Targets FLT3 receptor Transuzumab - Monoclonal antibody targeting human epidermal growth factor receptor 2 (HER2) Topoisomerases - Epirubicin Histone Deacetylase (HDAC) - Romidepsin (Rubraca) ...
[Show more]